Voya Corporate Leaders Trust Fund B Q4 2024 Commentary
For the quarter, Voya Corporates Leaders Trust Fund Series B underperformed its benchmark, S&P 500 Index on a net asset value ...
Akebia Therapeutics gets EU positive recommendation for Xoanacyl
Akebia Therapeutics gets EMA panel support for Xoanacyl to treat high phosphate & iron deficiency in CKD. Read more here.